How many episodes does WolverHeme Happy Hour have?

WolverHeme Happy Hour has 108 episodes.

What topics does WolverHeme Happy Hour cover?

WolverHeme Happy Hour covers topics including: health, fitness, medicine.

What language is WolverHeme Happy Hour in?

WolverHeme Happy Hour is in en.

WolverHeme Happy Hour

Bernard Marini, Anthony Perissinotti, et al.

EN108 episodes

healthfitnessmedicine

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks!Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Episodes (108)

Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology

WolverHeme Happy Hour

Apr 13, 20261:01:29failed

HLH: From Chaos to Clarity... and Back to Chaos!

WolverHeme Happy Hour

Mar 20, 20261:04:40failed

An Exercise in Uncertainty with Jonathan Gluck

WolverHeme Happy Hour

Feb 10, 202646:18pending

WolverHeme Happy Hour

Episodes (108)

Spring Cleaning the Evidence from ASH 2025 with Common Sense Oncology

HLH: From Chaos to Clarity... and Back to Chaos!

An Exercise in Uncertainty with Jonathan Gluck

ASH Leukemia Review: the more we learn, the less we know!

RIP 7+3 (1973-2025)? Why PARADIGM Doesn't Deliver the Eulogy

MajesTEC-3 and ASH 2025: Let's get "TEC"nical

Episode 40: Coffee and Community Hematology

Chill For 5: The Febrile Neutropenia Survival Guide

Episode 38: Prophy and Pints!

Episode 37: Spilling Drinks over Cytarabine Dosing

Episode 36: ODAC - Our Decisions Are Confusing

CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined

Dex and the Cytokine City: Managing CRS with Bispecifics

LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML

Episode 32: Navigating a BlinatumoMAD World

The Aquila Study: Blowing Hot Air or a Soaring Success for Smoldering Multiple M...

Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates

A Bunch of ASHholes Discuss Myeloma Abstracts

Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma

Episode 27: Mantle Cell Masterclass with Tycel Phillips

Houston, we don't have a problem... with APOLLO

From Ancient Remedies to Modern Miracles: The Evolution of APL Treatment

Episode 24: Myeloma Madness with the Myeloma Man

Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion

LymphOMG: Pouring Over Lymphoma Abstracts from ASH

AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Al...

ASH Pregaming - Myeloma Madness with Manni and Papa Heme

AML Maintenance Part 2: a metaMORPHOsis?

AML Maintenance Part 1: Set Your QUAZARs to Stun

Episode 17: The Hemophilia Eras Tour

Common Sense Oncology: Outcomes That Matter

All too well: the reality of leukemia treatment

Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr...

Episode 13: You get blinatumomab! You get blinatumomab!

Episode 12: Tinder for T Cells - Bispecifics in DLBCL

Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Ly...

Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme

Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with D...

Episode (3+)7: Straight Outta Roswell - OG AML Data

Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Aspar...

Episode 5: IDH Inhibitors in AML: not so AGILE

Episode 4: All Aboard the Oncology StewardSHIP

Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the...

Episode 2: We Don't Talk About Rylaze

Episode 1: Surrogate Endpoints in AML